Press Releases
CluePoints Builds on Late Phase work in Japan and Launches Risk-Based Monitoring Roadshow in Tokyo
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has further expanded its Late Phase work in...
Articles
Auditory Therapy, Ototoxicity and GLP Compliance Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve?
The numbers are daunting – 15% of the global population suffers from hearing loss, including a significant number of children, teenagers, and the elderly....
Industry Reports
Celonic Acquires Glycotope’s Bio-manufacturing Facility
Celonic AG, a leading global biologics development and manufacturing services provider, and Glycotope, a clinical stage immune-oncology company, today announced the successful completion of...
Articles
Direct-to-Patient Solutions Assuring Patient Participation and Retention in Clinical Trials
The average cost of bringing a new drug to market is $2.6 billion, according to a 2014 report published by Tufts Center for the...
News
Singapore eDevelopment’s Biomedical Subsidiary Confirms 100% Repellency of 3F Mosquito Fragrance
Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife") has completed development and testing of mosquito...
Press Releases
Cristal Therapeutics Progresses Nanomedicine CriPec®-docetaxel to Phase 1b Development in Patients with Solid Tumours
Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announced...
Press Releases
The future is now – Pharmapack Europe 2018 to showcase evolution and revolution in packaging and drug delivery
Pharmapack Europe 2018 announced the comprehensive event programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition taking place on 7–8 February...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read